Designed to make market research more actionable and strategically valuable, The Business Research Company’s 2026 market reports feature market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Protein Engineering Market Revenue Expansion Outlook For The 2026–2030 Forecast Period
The protein engineering market size has experienced rapid expansion in recent years. It is projected to grow from $4.62 billion in 2025 to $5.31 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 14.8%. This historical growth can be attributed to several factors including the expansion of biopharmaceutical research activities, the increasing availability of advanced laboratory instruments, a rise in academic protein research, growing investments in biotechnology, and enhancements in protein characterization methods.
The protein engineering market size is projected to experience substantial growth over the next few years. It is anticipated to expand to $9.3 billion by 2030, achieving a compound annual growth rate (CAGR) of 15.1%. The growth observed during this forecast period can be attributed to factors like the increasing demand for next-generation biologics, the expansion of personalized medicine, the growing application of engineered proteins in vaccines, the rising adoption of computational biology, and enhanced collaboration between industry and academia. Significant trends for the forecast period include the increasing uptake of rational protein design techniques, the rising utilization of AI in protein modeling, a growing demand for engineered therapeutic proteins, the expansion of custom protein engineering services, and the improved integration of bioinformatics tools.
Download A Free Sample For In-Depth Protein Engineering Market Intelligence:
Protein Engineering Market Demand Driver: How It Is Shaping Industry Growth
The increasing demand for protein-based drugs is a significant factor driving the protein engineering market. Proteins employed in drugs for their therapeutic activity are classified as protein-based drugs. These protein-based drugs, also known as therapeutic proteins, are medicines created as genetically engineered versions of naturally occurring human proteins. Protein engineering involves modifying protein sequences through the substitution, insertion, or deletion of nucleotides within the gene that encodes them, to develop protein-based drugs that are better suited for particular applications. For example, according to a study by Lancet Diabetes and Endocrinology journal, nearly 80 million people with type-2 diabetes will require insulin by 2030, indicating a rise of 20%. Thus, the escalating demand for protein-based drugs is a key driver for the protein engineering market.
Protein Engineering Market Segmentation Overview: Detailed Category Analysis
The protein engineering market covered in this report is segmented –
1) By Product And Services: Instruments, Reagents, Services And Software
2) By Technology: Irrational Protein Design, Rational Protein Design
3) By End User: Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations
Subsegments:
1) By Instruments: Protein Purification Systems, Spectroscopy And Imaging Systems, Mass Spectrometers
2) By Reagents: Enzymes, Antibodies, Labeling And Detection Reagents
3) By Services And Software: Custom Protein Engineering Services, Analytical Services, Consulting Services, Modeling And Simulation Software, Data Analysis Software, Bioinformatics Tools
Top Protein Engineering Market Trends And Recent Industry Developments
Major companies within the protein engineering market are developing groundbreaking products utilizing advanced technologies, such as the SUREtechnology platform, to improve the stability, efficacy, and manufacturability of therapeutic proteins. This SUREtechnology platform enables precise modifications, facilitating the creation of next-generation biologics that offer enhanced therapeutic properties, reduced side effects, and increased production efficiency. For instance, in September 2023, KBI Biopharma, a US-based biotechnology company, launched SUREmAb, an innovative product built on its SUREtechnology platform. This offering focuses on optimized, safe, and cost-efficient monoclonal antibody (mAb) development and manufacturing, addressing the rising demand for biopharmaceuticals. SUREmAb streamlines the process, allowing for rapid progression from transfection to Research Cell Bank (RCB) in just 9 weeks and enabling drug substance release within 11 months.
Protein Engineering Market Company Landscape: Key Players To Watch
Major companies operating in the protein engineering market are Codexis Inc., GenScript Biotech Corporation, Abzena plc, Aragen Bioscience Inc., Enantis s.r.o., Creative BioMart, Twist Bioscience Corporation, Ginkgo Bioworks Inc., Amyris Inc., Absci Corporation, Generate Biomedicines Inc., ProteinQure Inc., Zymeworks Inc., Adimab LLC, Ichnos Sciences SA, Synthego Corporation, Evotec SE, Pieris Pharmaceuticals Inc., MacroGenics Inc., Adagene Inc.
Explore The Protein Engineering Global Market Report For Full Insights:
Protein Engineering Market Region-Wise Analysis: Largest Regional Market Identified
North America was the largest region in the protein engineering market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein engineering market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
